New synthetic technology for medicines and fine chemicals

Sequential addition of starting materials enables continuous production of the final compound, rolipram.
Sequential addition of starting materials enables continuous production of the final compound, rolipram.

Direct continuous synthesis of medicines becomes possible

A University of Tokyo research group has succeeded in synthesizing (R)- and (S)-rolipram, the active component of a medicine, in high yield with high selectivity by an innovative catalyzed flow fine synthesis instead of the traditional batch method used in the production of 99% of medicines.

Professor Shu Kobayashi’s group at the Graduate School of Science has developed highly active immobilized catalysts (heterogeneous catalysts) and demonstrated simple and highly efficient synthesis of (R)- and (S)-rolipram by an eight-step continuous flow reaction using multiple column reactors containing the immobilized catalysts.

Currently, the active components of medicines as well as other fine chemicals are synthesized by a repeated batch reaction method, in which all starting materials are mixed in reaction vessels and the desired compounds are extracted after the all reactions have finished. In this method excess energy and operational steps are needed and a significant amount of waste is generated.

Read more: New synthetic technology for medicines and fine chemicals

 

The Latest on: Synthetic technology

[google_news title=”” keyword=”Synthetic technology” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]

via Google News

See Also

 

The Latest on: Synthetic technology

via  Bing News

 

What's Your Reaction?
Don't Like it!
0
I Like it!
0
Scroll To Top